Literature DB >> 2221439

Resistance to d-tubocurarine in lower motor neuron injury is related to increased acetylcholine receptors at the neuromuscular junction.

C W Hogue1, M S Itani, J A Martyn.   

Abstract

The hypothesis that lower motor neuron injury, with its associated proliferation of acetylcholine receptors (AChR), induces resistance to the neuromuscular effects of d-tubocurarine (dTC) was tested in the rat. The left gastrocnemius was denervated by a 75-80% lesion of the sciatic nerve. The effective dose for 95% twitch depression (ED95) was studied in the denervated gastrocnemius and compared to the contralateral undenervated and sham-injured (control) gastrocnemius muscles approximately 2 weeks after injury. The AChR number was quantitated by the specific ligand 125I-alpha-bungarotoxin (125I-alpha-BT). Plasma dTC concentrations, measured by high-performance liquid chromatography (HPLC), were correlated to twitch tension during spontaneous recovery from neuromuscular blockade in the denervated animal. The ED95 (mean +/- SE) of dTC for the denervated leg was significantly (P less than 0.05) higher (0.26 +/- 0.06 mg.kg-1) than contralateral (0.16 +/- 0.03) and sham-operated left (0.13 +/- 0.03) legs. The twitch tension recovered to 50% of control twitch height at significantly (P less than 0.05) higher plasma dTC concentrations in the denervated (0.78 micrograms.ml-1) compared to contralateral (0.24 micrograms.ml-1) limb. The AChR number was significantly increased in the denervated limb (1041 +/- 96 fmol.mg protein-1) compared to contralateral right (109 +/- 4) and control left limb (113 +/- 11). There was a significant (P less than 0.05) positive correlation (R2 = 0.73) between ED95 and AChR number; that is, 73% of the variability in ED95 could be explained by changes in AChR. This study, therefore, confirms the hypothesis that proliferation of AChR after nerve denervation results in resistance to the neuromuscular effects of dTC.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2221439     DOI: 10.1097/00000542-199010000-00016

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  7 in total

1.  Potency of nondepolarizing muscle relaxants on muscle-type acetylcholine receptors in denervated mouse skeletal muscle.

Authors:  Hong WANG; Bin YANG; Guang-wei HAN; Shi-tong LI
Journal:  Acta Pharmacol Sin       Date:  2010-11-22       Impact factor: 6.150

2.  Effects of tensile stress on the alpha1 nicotinic acetylcholine receptor expression in maxillofacial skeletal myocytes.

Authors:  Xiuping Wu; Hui Gao; Danna Xiao; Songjiao Luo; Zhihe Zhao
Journal:  Mol Cell Biochem       Date:  2007-12-28       Impact factor: 3.396

Review 3.  The acetylcholine receptor ligand-gated channel as a molecular target of disease and therapeutic agents.

Authors:  F J Barrantes
Journal:  Neurochem Res       Date:  1997-04       Impact factor: 3.996

4.  Different magnitude of resistance to nondepolarizing muscle relaxants in the denervated mouse skeletal muscle.

Authors:  Hong Wang; Bin Yang; Yong-fu Xu; Tao Yan; Shi-tong Li
Journal:  Acta Pharmacol Sin       Date:  2010-03-22       Impact factor: 6.150

Review 5.  Neuromuscular transmission and its pharmacological blockade. Part 2: Pharmacology of neuromuscular blocking agents.

Authors:  L H Booij
Journal:  Pharm World Sci       Date:  1997-02

Review 6.  Pharmacology, selection and complications associated with neuromuscular blocking drugs in ICU patients.

Authors:  R C Prielipp
Journal:  Yale J Biol Med       Date:  1998 Nov-Dec

7.  Decreased Spontaneous Electrical Activity and Acetylcholine at Myofascial Trigger Spots after Dry Needling Treatment: A Pilot Study.

Authors:  Qing-Guang Liu; Lin Liu; Qiang-Min Huang; Thi-Tham Nguyen; Yan-Tao Ma; Jia-Min Zhao
Journal:  Evid Based Complement Alternat Med       Date:  2017-05-16       Impact factor: 2.629

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.